Crossmark

7q11.23 dosage-dependent dysregulation in human pluripotent stem cells affects transcriptional programs in disease-relevant lineages

Crossref DOI link: https://doi.org/10.1038/ng.3169

Published Online: 2014-12-15

Published Print: 2015-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Adamo, Antonio

Atashpaz, Sina http://orcid.org/0000-0003-0566-5629
Germain, Pierre-Luc http://orcid.org/0000-0003-3418-4218
Zanella, Matteo

D'Agostino, Giuseppe

Albertin, Veronica

Chenoweth, Josh

Micale, Lucia

Fusco, Carmela

Unger, Christian

Augello, Bartolomeo

Palumbo, Orazio

Hamilton, Brad

Carella, Massimo

Donti, Emilio

Pruneri, Giancarlo

Selicorni, Angelo

Biamino, Elisa

Prontera, Paolo

McKay, Ronald

Merla, Giuseppe http://orcid.org/0000-0001-5078-928X
Testa, Giuseppe http://orcid.org/0000-0002-9104-0918
License Information

Text and Data Mining valid from 2014-12-15
More Information

Article History

Received: 30 September 2014

Accepted: 24 November 2014

First Online: 15 December 2014

Change Date: 9 January 2015

Change Type: Correction

Change Details: In the version of this article initially published online, <i>GTF1I</i> knockdown was incorrectly referred to in the legend for Figure 4c. <i>GTF2I</i> is the correct shRNA target in this experiment. The error has been corrected for the print, PDF and HTML versions of this article.

Competing interests

: B.H. is the director of research and development for Stemgent and Asterand. All other authors declare no competing financial interests.